Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

New class of macrolides developed at Abbott

Jan. 23, 1998

Desmycosin derivatives a focus of research at Pliva

Jan. 23, 1998

Streptogramins in the treatment of drug-resistant infections

Jan. 22, 1998

Innovative Therapies for Rheumatoid Arthritis

Jan. 22, 1998

Antischistosomal agent derived from myrrh tested in humans

Jan. 21, 1998

Malaria vaccine research under way at Gryphon Sciences

Jan. 21, 1998

Johns Hopkins researchers synthesize antimalarial drug candidates

Jan. 21, 1998

Potential target for a malaria vaccine identified

Jan. 21, 1998

PDMP analogues studied for malaria inhibition

Jan. 21, 1998

Preclinical evaluation of leishmaniasis Rx reported

Jan. 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...